Biotech Values

[DewDiligence]

VPHM DYAX – According to a discussion on today’s DYAX CC, VPHM will do the dirty work of locating individuals with HAE so that DYAX can come in and take over the market with a cheaper and more convenient alternative. Few people will actually want prophylactic treatment because it requires going to a clinic twice a week for an infusion.

Don’t shoot the messenger.